Novavax, Inc. (NVV1.F)
EUR 8.74
(0.66%)
EUR 8.74
(0.66%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.79 Billion USD | -20.42% |
| 2022 | 2.25 Billion USD | -12.34% |
| 2021 | 2.57 Billion USD | 62.83% |
| 2020 | 1.58 Billion USD | 814.96% |
| 2019 | 172.95 Million USD | -16.84% |
| 2018 | 207.97 Million USD | -31.25% |
| 2017 | 302.49 Million USD | -23.28% |
| 2016 | 394.3 Million USD | 2.14% |
| 2015 | 386.03 Million USD | 39.87% |
| 2014 | 276 Million USD | 16.98% |
| 2013 | 235.93 Million USD | 130.53% |
| 2012 | 102.34 Million USD | 53.73% |
| 2011 | 66.57 Million USD | -11.05% |
| 2010 | 74.84 Million USD | -12.57% |
| 2009 | 85.6 Million USD | 11.72% |
| 2008 | 76.62 Million USD | -16.07% |
| 2007 | 91.29 Million USD | -25.1% |
| 2006 | 121.87 Million USD | 44.43% |
| 2005 | 84.38 Million USD | 8.19% |
| 2004 | 77.99 Million USD | -7.33% |
| 2003 | 84.15 Million USD | 46.35% |
| 2002 | 57.5 Million USD | -14.32% |
| 2001 | 67.11 Million USD | 18.73% |
| 2000 | 56.52 Million USD | 1156.2% |
| 1999 | 4.5 Million USD | 18.42% |
| 1998 | 3.8 Million USD | -44.12% |
| 1997 | 6.8 Million USD | 19.3% |
| 1996 | 5.7 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.35 Billion USD | -24.7% |
| 2024 Q2 | 1.81 Billion USD | 34.36% |
| 2023 Q2 | 1.68 Billion USD | 9.23% |
| 2023 Q4 | 1.79 Billion USD | 8.47% |
| 2023 Q3 | 1.65 Billion USD | -1.66% |
| 2023 Q1 | 1.54 Billion USD | -31.7% |
| 2023 FY | 1.79 Billion USD | -20.42% |
| 2022 FY | 2.25 Billion USD | -12.34% |
| 2022 Q4 | 2.25 Billion USD | -0.39% |
| 2022 Q3 | 2.26 Billion USD | -13.56% |
| 2022 Q1 | 2.83 Billion USD | 10.02% |
| 2022 Q2 | 2.62 Billion USD | -7.47% |
| 2021 Q1 | 2.6 Billion USD | 64.83% |
| 2021 Q2 | 2.74 Billion USD | 5.41% |
| 2021 FY | 2.57 Billion USD | 62.83% |
| 2021 Q4 | 2.57 Billion USD | 0.42% |
| 2021 Q3 | 2.56 Billion USD | -6.68% |
| 2020 Q3 | 944.02 Million USD | 1.27% |
| 2020 FY | 1.58 Billion USD | 814.96% |
| 2020 Q2 | 932.22 Million USD | 184.16% |
| 2020 Q4 | 1.58 Billion USD | 67.63% |
| 2020 Q1 | 328.06 Million USD | 89.68% |
| 2019 Q4 | 172.95 Million USD | 4.94% |
| 2019 FY | 172.95 Million USD | -16.84% |
| 2019 Q2 | 189.38 Million USD | -14.43% |
| 2019 Q1 | 221.31 Million USD | 6.41% |
| 2019 Q3 | 164.81 Million USD | -12.98% |
| 2018 Q3 | 250.47 Million USD | -12.36% |
| 2018 FY | 207.97 Million USD | -31.25% |
| 2018 Q1 | 276.06 Million USD | -8.74% |
| 2018 Q2 | 285.8 Million USD | 3.53% |
| 2018 Q4 | 207.97 Million USD | -16.97% |
| 2017 Q2 | 355.7 Million USD | -1.6% |
| 2017 Q1 | 361.5 Million USD | -8.32% |
| 2017 FY | 302.49 Million USD | -23.28% |
| 2017 Q4 | 302.49 Million USD | -9.45% |
| 2017 Q3 | 334.07 Million USD | -6.08% |
| 2016 Q4 | 394.3 Million USD | -14.21% |
| 2016 Q1 | 592.5 Million USD | 53.48% |
| 2016 Q2 | 525 Million USD | -11.39% |
| 2016 Q3 | 459.62 Million USD | -12.45% |
| 2016 FY | 394.3 Million USD | 2.14% |
| 2015 Q3 | 404.63 Million USD | -4.72% |
| 2015 FY | 386.03 Million USD | 39.87% |
| 2015 Q1 | 438.84 Million USD | 59.0% |
| 2015 Q4 | 386.03 Million USD | -4.6% |
| 2015 Q2 | 424.69 Million USD | -3.22% |
| 2014 Q1 | 218.59 Million USD | -7.35% |
| 2014 Q3 | 292.51 Million USD | -6.24% |
| 2014 Q4 | 276 Million USD | -5.64% |
| 2014 Q2 | 311.99 Million USD | 42.72% |
| 2014 FY | 276 Million USD | 16.98% |
| 2013 Q2 | 92.91 Million USD | -5.86% |
| 2013 Q4 | 235.93 Million USD | -3.73% |
| 2013 Q3 | 245.07 Million USD | 163.75% |
| 2013 Q1 | 98.7 Million USD | -3.56% |
| 2013 FY | 235.93 Million USD | 130.53% |
| 2012 Q3 | 80.54 Million USD | 4.64% |
| 2012 FY | 102.34 Million USD | 53.73% |
| 2012 Q1 | 68.63 Million USD | 3.1% |
| 2012 Q2 | 76.97 Million USD | 12.15% |
| 2012 Q4 | 102.34 Million USD | 27.06% |
| 2011 Q3 | 67.08 Million USD | -3.26% |
| 2011 Q2 | 69.34 Million USD | -1.13% |
| 2011 Q1 | 70.13 Million USD | -6.29% |
| 2011 FY | 66.57 Million USD | -11.05% |
| 2011 Q4 | 66.57 Million USD | -0.76% |
| 2010 Q1 | 75.37 Million USD | -11.95% |
| 2010 FY | 74.84 Million USD | -12.57% |
| 2010 Q3 | 79.31 Million USD | 15.04% |
| 2010 Q4 | 74.84 Million USD | -5.64% |
| 2010 Q2 | 68.94 Million USD | -8.53% |
| 2009 FY | 85.6 Million USD | 11.72% |
| 2009 Q2 | 73.22 Million USD | 7.74% |
| 2009 Q3 | 75.88 Million USD | 3.63% |
| 2009 Q4 | 85.6 Million USD | 12.82% |
| 2009 Q1 | 67.96 Million USD | -11.31% |
| 2008 Q3 | 89.51 Million USD | 10.82% |
| 2008 Q2 | 80.77 Million USD | -6.31% |
| 2008 Q1 | 86.22 Million USD | -5.55% |
| 2008 FY | 76.62 Million USD | -16.07% |
| 2008 Q4 | 76.62 Million USD | -14.4% |
| 2007 Q3 | 99.7 Million USD | -7.71% |
| 2007 FY | 91.29 Million USD | -25.1% |
| 2007 Q1 | 115.39 Million USD | -5.32% |
| 2007 Q2 | 108.03 Million USD | -6.37% |
| 2007 Q4 | 91.29 Million USD | -8.44% |
| 2006 Q2 | 130.57 Million USD | -3.59% |
| 2006 Q1 | 135.43 Million USD | 60.5% |
| 2006 FY | 121.87 Million USD | 44.43% |
| 2006 Q4 | 121.87 Million USD | -2.79% |
| 2006 Q3 | 125.38 Million USD | -3.98% |
| 2005 Q4 | 84.38 Million USD | 39.37% |
| 2005 FY | 84.38 Million USD | 8.19% |
| 2005 Q3 | 60.54 Million USD | 0.41% |
| 2005 Q1 | 66.57 Million USD | -14.64% |
| 2005 Q2 | 60.29 Million USD | -9.43% |
| 2004 Q4 | 77.99 Million USD | -10.97% |
| 2004 Q3 | 87.6 Million USD | 17.4% |
| 2004 Q2 | 74.61 Million USD | -5.31% |
| 2004 Q1 | 78.8 Million USD | -6.37% |
| 2004 FY | 77.99 Million USD | -7.33% |
| 2003 FY | 84.15 Million USD | 46.35% |
| 2003 Q4 | 84.15 Million USD | 36.7% |
| 2003 Q3 | 61.56 Million USD | -3.67% |
| 2003 Q1 | 68.03 Million USD | 18.31% |
| 2003 Q2 | 63.9 Million USD | -6.07% |
| 2002 Q2 | 70.04 Million USD | 11.38% |
| 2002 Q3 | 62.22 Million USD | -11.17% |
| 2002 Q4 | 57.5 Million USD | -7.59% |
| 2002 FY | 57.5 Million USD | -14.32% |
| 2002 Q1 | 62.89 Million USD | -6.3% |
| 2001 Q2 | 57.38 Million USD | 5.61% |
| 2001 FY | 67.11 Million USD | 18.73% |
| 2001 Q1 | 54.33 Million USD | -3.89% |
| 2001 Q4 | 67.11 Million USD | -2.49% |
| 2001 Q3 | 68.83 Million USD | 19.95% |
| 2000 Q2 | 16.63 Million USD | -11.87% |
| 2000 Q1 | 18.87 Million USD | 319.51% |
| 2000 Q3 | 14.48 Million USD | -12.93% |
| 2000 Q4 | 56.52 Million USD | 290.21% |
| 2000 FY | 56.52 Million USD | 1156.2% |
| 1999 Q4 | 4.5 Million USD | 0.0% |
| 1999 Q2 | 5.5 Million USD | 83.33% |
| 1999 Q1 | 3 Million USD | -21.05% |
| 1999 Q3 | 4.5 Million USD | -18.18% |
| 1999 FY | 4.5 Million USD | 18.42% |
| 1998 Q1 | 12.1 Million USD | 77.94% |
| 1998 Q4 | 3.8 Million USD | -62.0% |
| 1998 Q2 | 11.1 Million USD | -8.26% |
| 1998 FY | 3.8 Million USD | -44.12% |
| 1998 Q3 | 10 Million USD | -9.91% |
| 1997 Q4 | 6.8 Million USD | -8.11% |
| 1997 FY | 6.8 Million USD | 19.3% |
| 1997 Q2 | 8.6 Million USD | -9.47% |
| 1997 Q1 | 9.5 Million USD | 66.67% |
| 1997 Q3 | 7.4 Million USD | -13.95% |
| 1996 Q2 | 6 Million USD | -11.76% |
| 1996 Q4 | 5.7 Million USD | 7.55% |
| 1996 Q3 | 5.3 Million USD | -11.67% |
| 1996 Q1 | 6.8 Million USD | 0.0% |
| 1996 FY | 5.7 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| BioNTech SE | 23 Billion EUR | 92.187% |
| CureVac N.V. | 788.89 Million EUR | -127.848% |
| Biotest Aktiengesellschaft | 1.44 Billion EUR | -24.454% |
| Biotest Aktiengesellschaft | 1.44 Billion EUR | -24.454% |
| BRAIN Biotech AG | 70.93 Million EUR | -2433.924% |
| Formycon AG | 890.36 Million EUR | -101.883% |
| Heidelberg Pharma AG | 70.35 Million EUR | -2454.957% |
| Medigene AG | 31.71 Million EUR | -5567.455% |